Spencer Ryan

Spencer Ryan is listed in filings as CEO and Director at Dynavax Technologies Corporation. This profile follows SEC Form 4 activity through Feb 10, 2026, including 31 public disclosures. Recent filings connect the profile to Dynavax Technologies Corporation (DVAX) and Cidara Therapeutics, Inc. (CDTX). The current snapshot covers public activity from Jul 19, 2024 to Feb 10, 2026. Reported amounts are shown as $4.5M to $2.9M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.